These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1357675)
21. Saccharin-induced increase in daily fluid intake as a predictor of voluntary alcohol intake in alcohol-preferring rats. Kampov-Polevoy AB; Overstreet DH; Rezvani AH; Janowsky DS Physiol Behav; 1995 Apr; 57(4):791-5. PubMed ID: 7777619 [TBL] [Abstract][Full Text] [Related]
22. Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Rezvani AH; Overstreet DH; Janowsky DS Alcohol Alcohol Suppl; 1991; 1():433-7. PubMed ID: 1845573 [TBL] [Abstract][Full Text] [Related]
23. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Schmidt CJ; Black CK; Abbate GM; Taylor VL Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848 [TBL] [Abstract][Full Text] [Related]
24. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY; Hsu FL Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [TBL] [Abstract][Full Text] [Related]
25. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Overstreet DH; Lee YW; Rezvani AH; Pei YH; Criswell HE; Janowsky DS Alcohol Clin Exp Res; 1996 Apr; 20(2):221-7. PubMed ID: 8730211 [TBL] [Abstract][Full Text] [Related]
26. Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement. Moreno-Sanz G; O'Shea E; Orio L; Escobedo I; González-Cuevas G; Navarro M; Colado MI; López-Moreno JA Int J Neuropsychopharmacol; 2009 Aug; 12(7):929-40. PubMed ID: 19236733 [TBL] [Abstract][Full Text] [Related]
27. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Chu T; Kumagai Y; DiStefano EW; Cho AK Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874 [TBL] [Abstract][Full Text] [Related]
28. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration. Colado MI; O'Shea E; Granados R; Esteban B; Martín AB; Green AR Br J Pharmacol; 1999 Feb; 126(4):911-24. PubMed ID: 10193771 [TBL] [Abstract][Full Text] [Related]
29. Reduced 5-HT3 receptor binding and lower baseline plus maze anxiety in the alcohol-preferring inbred fawn-hooded rat. Hensler JG; Hodge CW; Overstreet DH Pharmacol Biochem Behav; 2004 Feb; 77(2):281-9. PubMed ID: 14751456 [TBL] [Abstract][Full Text] [Related]
30. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone. Myers RD; Lankford MF Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536 [TBL] [Abstract][Full Text] [Related]
32. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Li AA; Marek GJ; Vosmer G; Seiden LS Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905 [TBL] [Abstract][Full Text] [Related]
33. MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system. Pan HS; Wang RY Brain Res; 1991 Jan; 539(2):332-6. PubMed ID: 1675911 [TBL] [Abstract][Full Text] [Related]
34. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats. Nash JF; Arora RC; Schreiber MA; Meltzer HY Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633 [TBL] [Abstract][Full Text] [Related]
36. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). Sprague JE; Banks ML; Cook VJ; Mills EM J Pharmacol Exp Ther; 2003 Apr; 305(1):159-66. PubMed ID: 12649364 [TBL] [Abstract][Full Text] [Related]
37. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Spanos LJ; Yamamoto BK Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003 [TBL] [Abstract][Full Text] [Related]
38. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats. Stanley N; Salem A; Irvine RJ Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465 [TBL] [Abstract][Full Text] [Related]
39. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). Sharkey J; McBean DE; Kelly PA Psychopharmacology (Berl); 1991; 105(1):113-8. PubMed ID: 1684057 [TBL] [Abstract][Full Text] [Related]
40. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. Callaway CW; Geyer MA J Pharmacol Exp Ther; 1992 Oct; 263(1):318-26. PubMed ID: 1357158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]